✦ LIBER ✦

Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: Greater doses of growth factor are necessary

✍ Scribed by Hye-Joung Kim; Gun-Il Im

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 464 KB
Volume: 27
Category: Article
ISSN: 0736-0266
DOI: 10.1002/jor.20766

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oncostatin M promotes osteogenesis and s

Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells

✍ Hae Young Song; Eun Su Jeon; Jung Il Kim; Jin Sup Jung; Jae Ho Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB 👁 1 views

## Abstract Oncostatin M (OSM) is a multifunctional cytokine of the interleukin‐6 family and has been implicated in embryonic development, differentiation, inflammation, and regeneration of liver and bone. In the present study, we demonstrated that treatment of human adipose mesenchymal stem cells

Effect of dual growth factor delivery on

Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites

✍ Hansoo Park; Johnna S. Temenoff; Yasuhiko Tabata; Arnold I. Caplan; Robert M. Ra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

## Abstract An injectable hydrogel composite consisting of oligo(poly(ethylene glycol)fumarate) (OPF) and gelatin microparticles has been developed as a novel carrier system for cells and growth factors. Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insuli

Adenoviral expression of vascular endoth

Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells

✍ Huey Lin; Arsalan Shabbir; Merced Molnar; Jingwei Yang; Susan Marion; John M. Ca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

## Abstract Bone marrow‐derived mesenchymal stem cells (MSCs) are being explored for clinical applications, and genetic engineering represents a useful strategy for boosting the therapeutic potency of MSCs. Vascular endothelial growth factor (VEGF)‐based gene therapy protocols have been used to tre